Decorin reduces hypertrophic scarring through inhibition of the TGF-β1/Smad signaling pathway in a rat osteomyelitis model

Chronic osteomyelitis is a bone infection that results in hypertrophic scarring of the soft tissue surrounding the infected bone. This scarring can create functional problems and its treatment is challenging. The aim of the present study was to evaluate the efficacy of decorin in treating scar formation in osteomyelitis and the underlying mechanism of its action. A rat osteomyelitis model was used, and animals were divided into three groups, as follows: Group A (control), group B (osteomyelitis model) and group C (decorin-treated). X-ray scans, hematoxylin and eosin (H&E) staining and Masson's trichrome staining were performed to observe changes in femur and muscle tissue. In order to assess the role of the transforming growth factor β1 (TGF-β1)/Smad signaling pathway in scar formation in osteomyelitis, alterations in muscle tissue morphology and in the activation of key members of the TGF-β1/Smad signaling pathway were investigated in groups A and B. According to the results of H&E staining, evident fibrosis in muscle tissue were observed at days 14 and 28 in group B. Simultaneously, the expression levels of key members of the TGF-β1/Smad signaling pathway were increased. Subsequent to treatment with decorin in group C, scarring was reduced, and significant downregulation of collagen I, TGF-β1, phosphorylated (p)Smad2 and pSmad3 protein expression levels was observed at days 14 and 28 compared with the osteomyelitis group. In conclusion, these results suggest that activation of TGF-β1 may serve an important role in the formation of scars in osteomyelitis and that decorin can reduce scar formation in an osteomyelitis rat model through inhibition of the TGF-β1/Smad signaling pathway.

[1]  R. Sun,et al.  Rapid method for protein quantitation by Bradford assay after elimination of the interference of polysorbate 80. , 2016, Analytical biochemistry.

[2]  G. Nath,et al.  Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model , 2016, The Indian journal of medical research.

[3]  D. Leavesley,et al.  Shikonin reduces TGF-β1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts , 2015, International journal of molecular medicine.

[4]  X. Bai,et al.  Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF‐β/Smad pathway , 2015, Experimental dermatology.

[5]  E. Kaya,et al.  Extracorporeal shockwave increases the effectiveness of systemic antibiotic treatment in implant‐related chronic osteomyelitis: Experimental study in a rat model , 2014, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[6]  Z. Ahmed,et al.  Decorin blocks scarring and cystic cavitation in acute and induces scar dissolution in chronic spinal cord wounds , 2014, Neurobiology of Disease.

[7]  A. Lewin,et al.  Triple combination of siRNAs targeting TGFβ1, TGFβR2, and CTGF enhances reduction of collagen I and smooth muscle actin in corneal fibroblasts. , 2013, Investigative ophthalmology & visual science.

[8]  M. Bhandari,et al.  Distraction osteogenesis in the treatment of long bone defects of the lower limbs: effectiveness, complications and clinical results; a systematic review and meta-analysis. , 2013, The bone & joint journal.

[9]  G. Buncke,et al.  Long-Term Results and Costs of Muscle Flap Coverage With Ilizarov Bone Transport in Lower Limb Salvage , 2013, Journal of orthopaedic trauma.

[10]  Zhi-bo Xiao,et al.  Hepatocyte Growth Factor Reduces Hypertrophy of Skin Scar: In Vivo Study , 2013, Advances in skin & wound care.

[11]  J. Engel,et al.  The crucial role of trimerization domains in collagen folding. , 2012, The international journal of biochemistry & cell biology.

[12]  E. Berbari,et al.  Osteomyelitis: review of pathophysiology, diagnostic modalities and therapeutic options. , 2012, Le Journal medical libanais. The Lebanese medical journal.

[13]  M. Yusuf,et al.  Chronic osteomyelitis in the lower extremity predisposing to the unusual formation of keloids. , 2011, Singapore medical journal.

[14]  R. Galiano,et al.  The effects of collagenase ointment on the prevention of hypertrophic scarring in a rabbit ear scarring model: a pilot study. , 2011, Wounds : a compendium of clinical research and practice.

[15]  E. Tredget,et al.  Small leucine‐rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar , 2011, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[16]  T. McKay,et al.  Gene delivery of a mutant TGFβ3 reduces markers of scar tissue formation after cutaneous wounding. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  Hong Chen,et al.  Effects of osthole on apoptosis and TGF-β1 of hypertrophic scar fibroblasts , 2009, Journal of Asian natural products research.

[18]  M. Gyetko,et al.  Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast. , 2009, Current medicinal chemistry.

[19]  A. Tzankov,et al.  Hypertrophic Scars and Keloids—A Review of Their Pathophysiology, Risk Factors, and Therapeutic Management , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[20]  K. Luo,et al.  Ski and SnoN, potent negative regulators of TGF-β signaling , 2009, Cell Research.

[21]  T. Nishimura,et al.  Decorin enhances the proliferation and differentiation of myogenic cells through suppressing myostatin activity , 2008, Journal of cellular physiology.

[22]  F. Ambrosio,et al.  Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. , 2007, The Journal of biological chemistry.

[23]  Ye-yang Li,et al.  Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts. , 2007, Burns : journal of the International Society for Burn Injuries.

[24]  S. Phan,et al.  Therapies for bleomycin induced lung fibrosis through regulation of TGF‐β1 induced collagen gene expression , 2007, Journal of cellular physiology.

[25]  T. Nishimura,et al.  Decorin binds myostatin and modulates its activity to muscle cells. , 2006, Biochemical and biophysical research communications.

[26]  T. McGaha,et al.  Molecular Aspects of Regulation of Collagen Gene Expression in Fibrosis , 2005, Journal of Clinical Immunology.

[27]  J. Mader,et al.  Long bone osteomyelitis , 2002, Current infectious disease reports.

[28]  Marian F Young,et al.  Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. , 2002, Glycobiology.

[29]  Johnny Huard,et al.  The Use of an Antifibrosis Agent to Improve Muscle Recovery after Laceration * , 2001, The American journal of sports medicine.

[30]  P. Sime,et al.  Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[31]  Paul G Scott,et al.  A Role for Decorin in the Structural Organization of Periodontal Ligament , 2000, Laboratory Investigation.

[32]  L. L. Pu,et al.  Exogenous transforming growth factor beta(2) modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. , 1999, The Journal of surgical research.

[33]  M. Whitman.  Smads and early developmental signaling by the TGFbeta superfamily. , 1998, Genes & development.

[34]  R. Iozzo.  Matrix proteoglycans: from molecular design to cellular function. , 1998, Annual review of biochemistry.

[35]  J. Massagué.  TGFβ Signaling: Receptors, Transducers, and Mad Proteins , 1996, Cell.

[36]  J. Massagué.  TGFbeta signaling: receptors, transducers, and Mad proteins. , 1996, Cell.

[37]  M E Bolander,et al.  Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur , 1990, The Journal of cell biology.

[38]  S. Jimenez,et al.  Evaluation of transforming growth factor beta and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. , 1990, The Journal of investigative dermatology.